Department of Cardiology, School of Medicine, Gulhane Military Medical Academy, Etlik-Ankara, Turkey.
Clinics (Sao Paulo). 2011;66(10):1729-34. doi: 10.1590/s1807-59322011001000010.
This retrospective study aimed to investigate the relationship between admission levels of serum y-glutamyltransferase and poor myocardial perfusion after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Reperfusion injury caused by free radical release and increased oxidative stress is responsible for the pathophysiology of the no-reflow phenomenon in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Serum γ-glutamyltransferase is an established marker of increased oxidative stress.
The study population consisted of 80 patients (64 men and 16 women, mean age = 67.5 + 6.6 years) with thrombolysis in myocardial infarction 0/1 flow pre-procedurally. The patients were divided into two groups according to thrombolysis in myocardial perfusion grades that were assessed immediately following primary percutaneous coronary intervention. The two groups (group 1 and group 2) each consisted of 40 patients with thrombolysis in myocardial perfusion grades 0-1 and thrombolysis in myocardial perfusion grades 2-3, respectively.
Admission pain to balloon time, γ-glutamyltransferase and creatine kinase-MB isoenzyme levels of group 1 patients were significantly higher than those of group 2 patients. Pain to balloon time, γ-glutamyltransferase, peak creatine kinase-MB isoenzyme, low left ventricular ejection fraction and poor pre-procedural thrombolysis in myocardial infarction grade were significantly associated with poor myocardial perfusion by univariate analysis. However, only pain to balloon time and γ-glutamyltransferase levels showed a significant independent association with poor myocardial perfusion by backward logistic regression analysis. Adjusted odds ratios were calculated as 4.92 for pain to balloon time and 1.13 for γ-glutamyltransferase.
High admission γ-glutamyltransferase levels are associated with poor myocardial perfusion in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, particularly in patients with prolonged pain to balloon time.
本回顾性研究旨在探讨急性心肌梗死患者行直接经皮冠状动脉介入治疗(PPCI)后入院时血清γ-谷氨酰转移酶水平与心肌灌注不良之间的关系。
自由基释放和氧化应激增加引起的再灌注损伤是导致行 PPCI 的急性心肌梗死患者无复流现象的病理生理学基础。血清γ-谷氨酰转移酶是氧化应激增加的既定标志物。
研究人群包括 80 例患者(64 名男性和 16 名女性,平均年龄=67.5+6.6 岁),这些患者在 PPCI 前的心肌梗死溶栓治疗(TIMI)血流 0/1 级。根据 PPCI 后即刻评估的 TIMI 心肌灌注分级,将患者分为两组。两组(组 1 和组 2)各包括 TIMI 心肌灌注分级 0-1 级和 TIMI 心肌灌注分级 2-3 级的 40 例患者。
组 1 患者的入院时疼痛至球囊时间、γ-谷氨酰转移酶和肌酸激酶同工酶 MB 水平显著高于组 2 患者。单因素分析显示,疼痛至球囊时间、γ-谷氨酰转移酶、肌酸激酶同工酶 MB 峰值、左心室射血分数低和术前 TIMI 分级差与心肌灌注不良显著相关。然而,只有疼痛至球囊时间和 γ-谷氨酰转移酶水平通过向后逻辑回归分析显示与心肌灌注不良有显著独立相关性。调整后的优势比计算为疼痛至球囊时间为 4.92,γ-谷氨酰转移酶为 1.13。
急性心肌梗死患者行 PPCI 后入院时γ-谷氨酰转移酶水平较高与心肌灌注不良相关,尤其是疼痛至球囊时间较长的患者。